LAM RESEARCH ($LRCX) posted quarterly earnings results on Wednesday, April 23rd. The company reported earnings of $1.04 per share, beating estimates of $1.02 by $0.02. The company also reported revenue of $4,720,180,000, missing estimates of $4,736,529,936 by $-16,349,936.
You can see Quiver Quantitative's $LRCX stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
LAM RESEARCH Insider Trading Activity
LAM RESEARCH insiders have traded $LRCX stock on the open market 3 times in the past 6 months. Of those trades, 0 have been purchases and 3 have been sales.
Here’s a breakdown of recent trading of $LRCX stock by insiders over the last 6 months:
- SESHASAYEE VARADARAJAN (Senior Vice President) has made 0 purchases and 2 sales selling 110,080 shares for an estimated $9,907,200.
- BETHANY MAYER sold 1,660 shares for an estimated $124,757
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
LAM RESEARCH Hedge Fund Activity
We have seen 35 institutional investors add shares of LAM RESEARCH stock to their portfolio, and 53 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- MENORA MIVTACHIM HOLDINGS LTD. added 1,381,450 shares (+inf%) to their portfolio in Q4 2024, for an estimated $99,782,133
- KOVITZ INVESTMENT GROUP PARTNERS, LLC added 1,035,052 shares (+341.9%) to their portfolio in Q4 2024, for an estimated $74,761,805
- DNB ASSET MANAGEMENT AS removed 673,402 shares (-41.6%) from their portfolio in Q4 2024, for an estimated $48,639,826
- DEKABANK DEUTSCHE GIROZENTRALE removed 556,236 shares (-90.0%) from their portfolio in Q4 2024, for an estimated $40,176,926
- RESONA ASSET MANAGEMENT CO.,LTD. removed 439,600 shares (-100.0%) from their portfolio in Q4 2024, for an estimated $31,752,308
- HUNTINGTON NATIONAL BANK removed 282,349 shares (-100.0%) from their portfolio in Q4 2024, for an estimated $20,394,068
- MEDIOLANUM INTERNATIONAL FUNDS LTD added 196,202 shares (+inf%) to their portfolio in Q4 2024, for an estimated $14,171,670
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
LAM RESEARCH Congressional Stock Trading
Members of Congress have traded $LRCX stock 9 times in the past 6 months. Of those trades, 4 have been purchases and 5 have been sales.
Here’s a breakdown of recent trading of $LRCX stock by members of Congress over the last 6 months:
- REPRESENTATIVE MARJORIE TAYLOR GREENE has traded it 2 times. They made 2 purchases worth up to $30,000 on 04/04, 11/25 and 0 sales.
- REPRESENTATIVE JEFFERSON SHREVE has traded it 2 times. They made 1 purchase worth up to $100,000 on 03/31 and 1 sale worth up to $100,000 on 03/05.
- SENATOR JOHN BOOZMAN sold up to $15,000 on 02/05.
- REPRESENTATIVE GILBERT RAY CISNEROS, JR. sold up to $50,000 on 01/28.
- REPRESENTATIVE WILLIAM R. KEATING sold up to $15,000 on 01/24.
- REPRESENTATIVE ROBERT BRESNAHAN purchased up to $15,000 on 01/16.
- SENATOR SHELDON WHITEHOUSE sold up to $50,000 on 12/19.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
LAM RESEARCH Analyst Ratings
Wall Street analysts have issued reports on $LRCX in the last several months. We have seen 2 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Cantor Fitzgerald issued a "Overweight" rating on 01/30/2025
- Bernstein issued a "Outperform" rating on 01/30/2025
To track analyst ratings and price targets for LAM RESEARCH, check out Quiver Quantitative's $LRCX forecast page.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
